Nirsevimab Clinical Guidance and VFC Ordering [Letter]

• 2024

  Log in to bookmark this resource.

  Log in
• Bindy Crouch

---

Access Resources

• Job AidEN
• Ask aRCie About This Resource

About

This letter provides clinical guidance on the use of nirsevimab (Beyfortus), a monoclonal antibody that protects infants and toddlers from respiratory syncytial virus (RSV). Information on ordering through the Vaccines for Children (VFC) program is also provided. Infants under 8 months during their first RSV season and high-risk children aged 8-19 months are eligible.

---

Tags

Focus Area: Infectious Disease

Audiences: Nurses; Physicians

Emergency Management Stage: Preparedness (Prevention / Protection)

Bundles: Nirsevimab Library

Keywords: Antibodies, Monoclonal; Child Health Services; Immunization, Passive; Infant; Infant, Newborn; Pregnant Women; Respiratory Syncytial Virus Infections; Respiratory Syncytial Viruses; Antibodies, Monoclonal, Humanized

Institutions: New York City Department of Health and Mental Hygiene

---

More like this

Notes from the Field: Rollout of Nirsevimab to Protect Infants and Young Children During the Respiratory Syncytial Virus Season — New York City, 2023–2024 2024 · New York City Department of Health and Mental Hygiene, Centers for Disease Control and Prevention (CDC) Strengthening Pediatric and Public Health Collaboration to Protect Children's Health During a Pandemic 2024 · U.S. Department of Health and Human Services (HHS), Albany Medical College, Adams County Health Department, Texas Medical Association, New York City Department of Health and Mental Hygiene, Los Angeles County Department of Public Health Children (9/11 Health) 2017 · New York City Department of Health and Mental Hygiene

---

The information provided on this website is for educational purposes only. It does not substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.

---